Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases

ISSN： 0785-3890

Source： Annals of Medicine, Vol.35, Iss.8, 2003-12, pp. : 640-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics in the treatment of rheumatoid arthritis: clinical implication and perspective

By Taniguchi Atsuo Yamanaka Hisashi Kamatani Naoyuki

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 151-163

Future Medicine

Access to resources Recommend Favorite

Improvement of vitiligo in a patient with rheumatoid arthritis after hydroxychloroquine treatment

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 6, 2015-07 ,pp. : 679-680

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generalization and Extrapolation of Treatment Effects From Clinical Studies in Rheumatoid Arthritis

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 998-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of early rheumatoid arthritis

By Raza Karim Salmon Mike Buckley Christopher D

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 659-668

Future Medicine

Access to resources Recommend Favorite

Promyelocytic Crisis of Chronic Myelogenous Leukaemia during Imatinib Mesylate Treatment

Acta Haematologica, Vol. 117, Iss. 4, 2006-12 ,pp. : 191-196

Karger

Access to resources Recommend Favorite